Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £26,316 | £27,485 | £31,676 | £33,444 |
| - Cash | £1,918 | £3,671 | £1,440 | £1,998 |
| + Debt | £1,028 | £1,009 | £1,049 | £1,008 |
| Enterprise Value | £25,426 | £24,823 | £31,285 | £32,454 |
| Revenue | £5,335 | £3,094 | £3,725 | £2,410 |
| % Growth | 72.4% | -16.9% | 54.6% | – |
| Gross Profit | £2,211 | £917 | £2,260 | £1,278 |
| % Margin | 41.4% | 29.6% | 60.7% | 53% |
| EBITDA | -£475 | -£2,326 | £266 | -£901 |
| % Margin | -8.9% | -75.2% | 7.1% | -37.4% |
| Net Income | -£894 | -£2,521 | -£66 | -£1,205 |
| % Margin | -16.8% | -81.5% | -1.8% | -50% |
| EPS Diluted | -0.002 | -0.007 | -0 | -0.004 |
| % Growth | 66.2% | -3,450% | 94.9% | – |
| Operating Cash Flow | -£959 | -£2,146 | -£460 | -£1,199 |
| Capital Expenditures | -£321 | -£6 | -£17 | -£18 |
| Free Cash Flow | -£1,280 | -£2,152 | -£477 | -£1,217 |